What is the true incidence of COVID-19 in patients with rheumatic diseases?
Identifieur interne : 000034 ( Main/Exploration ); précédent : 000033; suivant : 000035What is the true incidence of COVID-19 in patients with rheumatic diseases?
Auteurs : Ennio Giulio Favalli [Oman] ; Francesca Ingegnoli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie]Source :
- Annals of the rheumatic diseases [ 1468-2060 ] ; 2021.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Antirhumatismaux (usage thérapeutique), Arthrite juvénile (traitement médicamenteux), Arthrite juvénile (épidémiologie), Arthrite psoriasique (traitement médicamenteux), Arthrite psoriasique (épidémiologie), Enfant (MeSH), Femelle (MeSH), Hospitalisation (statistiques et données numériques), Humains (MeSH), Incidence (MeSH), Indice de gravité de la maladie (MeSH), Inhibiteurs des Janus kinases (usage thérapeutique), Italie (épidémiologie), Mâle (MeSH), Polyarthrite rhumatoïde (traitement médicamenteux), Polyarthrite rhumatoïde (épidémiologie), Rhumatismes (traitement médicamenteux), Rhumatismes (épidémiologie), Spondylarthropathies (traitement médicamenteux), Spondylarthropathies (épidémiologie), Sujet âgé (MeSH).
- MESH :
- statistiques et données numériques : Hospitalisation.
- traitement médicamenteux : Arthrite juvénile, Arthrite psoriasique, Polyarthrite rhumatoïde, Rhumatismes, Spondylarthropathies.
- usage thérapeutique : Antirhumatismaux, Inhibiteurs des Janus kinases.
- épidémiologie : Arthrite juvénile, Arthrite psoriasique, Italie, Polyarthrite rhumatoïde, Rhumatismes, Spondylarthropathies.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Femelle, Humains, Incidence, Indice de gravité de la maladie, Mâle, Sujet âgé.
- Wicri :
- geographic : Italie.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Antirheumatic Agents (therapeutic use), Arthritis, Juvenile (drug therapy), Arthritis, Juvenile (epidemiology), Arthritis, Psoriatic (drug therapy), Arthritis, Psoriatic (epidemiology), Arthritis, Rheumatoid (drug therapy), Arthritis, Rheumatoid (epidemiology), COVID-19 (epidemiology), Child (MeSH), Female (MeSH), Hospitalization (statistics & numerical data), Humans (MeSH), Incidence (MeSH), Italy (epidemiology), Janus Kinase Inhibitors (therapeutic use), Male (MeSH), Middle Aged (MeSH), Rheumatic Diseases (drug therapy), Rheumatic Diseases (epidemiology), SARS-CoV-2 (MeSH), Severity of Illness Index (MeSH), Spondylarthropathies (drug therapy), Spondylarthropathies (epidemiology), Tumor Necrosis Factor Inhibitors (therapeutic use).
- MESH :
- chemical , therapeutic use : Antirheumatic Agents, Janus Kinase Inhibitors, Tumor Necrosis Factor Inhibitors.
- geographic , epidemiology : Italy.
- drug therapy : Arthritis, Juvenile, Arthritis, Psoriatic, Arthritis, Rheumatoid, Rheumatic Diseases, Spondylarthropathies.
- epidemiology : Arthritis, Juvenile, Arthritis, Psoriatic, Arthritis, Rheumatoid, COVID-19, Rheumatic Diseases, Spondylarthropathies.
- statistics & numerical data : Hospitalization.
- Adolescent, Adult, Aged, Child, Female, Humans, Incidence, Male, Middle Aged, SARS-CoV-2, Severity of Illness Index.
DOI: 10.1136/annrheumdis-2020-217615
PubMed: 32321723
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">What is the true incidence of COVID-19 in patients with rheumatic diseases?</title><author><name sortKey="Favalli, Ennio Giulio" sort="Favalli, Ennio Giulio" uniqKey="Favalli E" first="Ennio Giulio" last="Favalli">Ennio Giulio Favalli</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy ennio.favalli@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation></author><author><name sortKey="Ingegnoli, Francesca" sort="Ingegnoli, Francesca" uniqKey="Ingegnoli F" first="Francesca" last="Ingegnoli">Francesca Ingegnoli</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation></author><author><name sortKey="Cimaz, Rolando" sort="Cimaz, Rolando" uniqKey="Cimaz R" first="Rolando" last="Cimaz">Rolando Cimaz</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Division of Pediatric Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Division of Pediatric Rheumatology, Gaetano Pini-CTO, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation></author><author><name sortKey="Caporali, Roberto" sort="Caporali, Roberto" uniqKey="Caporali R" first="Roberto" last="Caporali">Roberto Caporali</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2021">2021</date><idno type="RBID">pubmed:32321723</idno><idno type="pmid">32321723</idno><idno type="doi">10.1136/annrheumdis-2020-217615</idno><idno type="wicri:Area/Main/Corpus">001914</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001914</idno><idno type="wicri:Area/Main/Curation">001914</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001914</idno><idno type="wicri:Area/Main/Exploration">001914</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">What is the true incidence of COVID-19 in patients with rheumatic diseases?</title><author><name sortKey="Favalli, Ennio Giulio" sort="Favalli, Ennio Giulio" uniqKey="Favalli E" first="Ennio Giulio" last="Favalli">Ennio Giulio Favalli</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy ennio.favalli@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation></author><author><name sortKey="Ingegnoli, Francesca" sort="Ingegnoli, Francesca" uniqKey="Ingegnoli F" first="Francesca" last="Ingegnoli">Francesca Ingegnoli</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation></author><author><name sortKey="Cimaz, Rolando" sort="Cimaz, Rolando" uniqKey="Cimaz R" first="Rolando" last="Cimaz">Rolando Cimaz</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Division of Pediatric Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Division of Pediatric Rheumatology, Gaetano Pini-CTO, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation></author><author><name sortKey="Caporali, Roberto" sort="Caporali, Roberto" uniqKey="Caporali R" first="Roberto" last="Caporali">Roberto Caporali</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia</wicri:regionArea><wicri:noRegion>Lombardia</wicri:noRegion></affiliation></author></analytic><series><title level="j">Annals of the rheumatic diseases</title><idno type="eISSN">1468-2060</idno><imprint><date when="2021" type="published">2021</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Antirheumatic Agents (therapeutic use)</term><term>Arthritis, Juvenile (drug therapy)</term><term>Arthritis, Juvenile (epidemiology)</term><term>Arthritis, Psoriatic (drug therapy)</term><term>Arthritis, Psoriatic (epidemiology)</term><term>Arthritis, Rheumatoid (drug therapy)</term><term>Arthritis, Rheumatoid (epidemiology)</term><term>COVID-19 (epidemiology)</term><term>Child (MeSH)</term><term>Female (MeSH)</term><term>Hospitalization (statistics & numerical data)</term><term>Humans (MeSH)</term><term>Incidence (MeSH)</term><term>Italy (epidemiology)</term><term>Janus Kinase Inhibitors (therapeutic use)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Rheumatic Diseases (drug therapy)</term><term>Rheumatic Diseases (epidemiology)</term><term>SARS-CoV-2 (MeSH)</term><term>Severity of Illness Index (MeSH)</term><term>Spondylarthropathies (drug therapy)</term><term>Spondylarthropathies (epidemiology)</term><term>Tumor Necrosis Factor Inhibitors (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Antirhumatismaux (usage thérapeutique)</term><term>Arthrite juvénile (traitement médicamenteux)</term><term>Arthrite juvénile (épidémiologie)</term><term>Arthrite psoriasique (traitement médicamenteux)</term><term>Arthrite psoriasique (épidémiologie)</term><term>Enfant (MeSH)</term><term>Femelle (MeSH)</term><term>Hospitalisation (statistiques et données numériques)</term><term>Humains (MeSH)</term><term>Incidence (MeSH)</term><term>Indice de gravité de la maladie (MeSH)</term><term>Inhibiteurs des Janus kinases (usage thérapeutique)</term><term>Italie (épidémiologie)</term><term>Mâle (MeSH)</term><term>Polyarthrite rhumatoïde (traitement médicamenteux)</term><term>Polyarthrite rhumatoïde (épidémiologie)</term><term>Rhumatismes (traitement médicamenteux)</term><term>Rhumatismes (épidémiologie)</term><term>Spondylarthropathies (traitement médicamenteux)</term><term>Spondylarthropathies (épidémiologie)</term><term>Sujet âgé (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antirheumatic Agents</term><term>Janus Kinase Inhibitors</term><term>Tumor Necrosis Factor Inhibitors</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Italy</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis, Juvenile</term><term>Arthritis, Psoriatic</term><term>Arthritis, Rheumatoid</term><term>Rheumatic Diseases</term><term>Spondylarthropathies</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Arthritis, Juvenile</term><term>Arthritis, Psoriatic</term><term>Arthritis, Rheumatoid</term><term>COVID-19</term><term>Rheumatic Diseases</term><term>Spondylarthropathies</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Hospitalisation</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Arthrite juvénile</term><term>Arthrite psoriasique</term><term>Polyarthrite rhumatoïde</term><term>Rhumatismes</term><term>Spondylarthropathies</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirhumatismaux</term><term>Inhibiteurs des Janus kinases</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Arthrite juvénile</term><term>Arthrite psoriasique</term><term>Italie</term><term>Polyarthrite rhumatoïde</term><term>Rhumatismes</term><term>Spondylarthropathies</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Child</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>SARS-CoV-2</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Indice de gravité de la maladie</term><term>Mâle</term><term>Sujet âgé</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Italie</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32321723</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>02</Month></PubDate></JournalIssue><Title>Annals of the rheumatic diseases</Title><ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation></Journal><ArticleTitle>What is the true incidence of COVID-19 in patients with rheumatic diseases?</ArticleTitle><Pagination><MedlinePgn>e18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-217615</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Favalli</LastName><ForeName>Ennio Giulio</ForeName><Initials>EG</Initials><Identifier Source="ORCID">0000-0003-1471-6467</Identifier><AffiliationInfo><Affiliation>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy ennio.favalli@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingegnoli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-6727-1273</Identifier><AffiliationInfo><Affiliation>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cimaz</LastName><ForeName>Rolando</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caporali</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano, Lombardia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milano, Lombardia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Rheum Dis</MedlineTA><NlmUniqueID>0372355</NlmUniqueID><ISSNLinking>0003-4967</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075242">Janus Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000079424">Tumor Necrosis Factor Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Rheumatol Int. 2020 Aug;40(8):1351-1352</RefSource><PMID Version="1">32514608</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001171" MajorTopicYN="N">Arthritis, Juvenile</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015535" MajorTopicYN="N">Arthritis, Psoriatic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075242" MajorTopicYN="N">Janus Kinase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="N">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025242" MajorTopicYN="N">Spondylarthropathies</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079424" MajorTopicYN="N">Tumor Necrosis Factor Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">arthritis</Keyword><Keyword MajorTopicYN="Y">biological therapy</Keyword><Keyword MajorTopicYN="Y">hydroxychloroquine</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32321723</ArticleId><ArticleId IdType="pii">annrheumdis-2020-217615</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2020-217615</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Italie</li><li>Oman</li></country></list><tree><country name="Oman"><noRegion><name sortKey="Favalli, Ennio Giulio" sort="Favalli, Ennio Giulio" uniqKey="Favalli E" first="Ennio Giulio" last="Favalli">Ennio Giulio Favalli</name></noRegion></country><country name="Italie"><noRegion><name sortKey="Ingegnoli, Francesca" sort="Ingegnoli, Francesca" uniqKey="Ingegnoli F" first="Francesca" last="Ingegnoli">Francesca Ingegnoli</name></noRegion><name sortKey="Caporali, Roberto" sort="Caporali, Roberto" uniqKey="Caporali R" first="Roberto" last="Caporali">Roberto Caporali</name><name sortKey="Caporali, Roberto" sort="Caporali, Roberto" uniqKey="Caporali R" first="Roberto" last="Caporali">Roberto Caporali</name><name sortKey="Cimaz, Rolando" sort="Cimaz, Rolando" uniqKey="Cimaz R" first="Rolando" last="Cimaz">Rolando Cimaz</name><name sortKey="Cimaz, Rolando" sort="Cimaz, Rolando" uniqKey="Cimaz R" first="Rolando" last="Cimaz">Rolando Cimaz</name><name sortKey="Ingegnoli, Francesca" sort="Ingegnoli, Francesca" uniqKey="Ingegnoli F" first="Francesca" last="Ingegnoli">Francesca Ingegnoli</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000034 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000034 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32321723
|texte= What is the true incidence of COVID-19 in patients with rheumatic diseases?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32321723" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |